For example, infliximab, a bivalent IgG monoclonal antibody acting as a competitive inhibitor to TNF-α, reduced Aβ and tau pathology [8] and improved visual recognition memory [9] upon intracerebroventricular injection in transgenic mouse models of AD. The gene discussed is MAPT; the disease is Alzheimer disease.